PALA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 3.776
EU - Europa 2.663
AS - Asia 1.600
SA - Sud America 188
AF - Africa 37
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.290
Nazione #
US - Stati Uniti d'America 3.744
RU - Federazione Russa 865
PL - Polonia 567
IT - Italia 530
SG - Singapore 463
CN - Cina 391
HK - Hong Kong 250
IE - Irlanda 202
SE - Svezia 168
VN - Vietnam 162
BR - Brasile 152
KR - Corea 116
FR - Francia 80
DE - Germania 68
FI - Finlandia 62
JO - Giordania 49
IN - India 43
GB - Regno Unito 29
NL - Olanda 26
AU - Australia 24
BD - Bangladesh 24
CA - Canada 19
CH - Svizzera 18
ID - Indonesia 18
JP - Giappone 17
TR - Turchia 17
UA - Ucraina 16
ES - Italia 13
AR - Argentina 12
IQ - Iraq 12
ZA - Sudafrica 12
EC - Ecuador 9
BE - Belgio 8
MX - Messico 7
CI - Costa d'Avorio 6
CO - Colombia 6
AE - Emirati Arabi Uniti 5
CL - Cile 4
MY - Malesia 4
NG - Nigeria 4
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
LV - Lettonia 3
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
LT - Lituania 2
MM - Myanmar 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
Totale 8.290
Città #
Santa Clara 813
Warsaw 565
Ashburn 480
Singapore 338
Fairfield 304
Chandler 217
Hong Kong 205
Dublin 202
Seattle 148
Woodbridge 136
Cambridge 131
San Jose 119
Seoul 116
Wilmington 111
Milan 108
Beijing 100
Houston 100
Ann Arbor 70
Buffalo 70
Los Angeles 59
Dallas 58
Ho Chi Minh City 50
Princeton 49
Rome 49
Altamura 48
Lawrence 47
Hefei 44
The Dalles 44
Lauterbourg 40
Florence 36
Hanoi 36
Boston 30
Moscow 29
Jacksonville 28
Paris 28
Kent 26
San Diego 25
Shanghai 25
Munich 24
Melbourne 23
Mumbai 23
New York 23
Helsinki 22
Council Bluffs 20
São Paulo 20
Medford 19
Naples 17
Bern 16
Boardman 16
Tokyo 16
Dong Ket 14
Wageningen 13
Orem 12
Philadelphia 11
Bologna 10
Frankfurt am Main 10
Jakarta 10
Turin 10
Clifton 9
London 9
Brussels 8
Falls Church 8
San Francisco 8
Stockholm 8
Catania 7
Haiphong 7
Izmir 7
Montreal 7
Norwalk 7
Phoenix 7
Venice 7
Abidjan 6
Andover 6
Baghdad 6
Figino 6
Guangzhou 6
Istanbul 6
Johannesburg 6
Redondo Beach 6
Toronto 6
Amman 5
Chicago 5
Da Nang 5
Falkenstein 5
Hillsboro 5
Miano 5
Padua 5
Palermo 5
Perugia 5
Quito 5
Tianjin 5
Turku 5
Bari 4
Bolzano 4
Brasília 4
Charlotte 4
Chennai 4
Dhaka 4
Mexico City 4
Parma 4
Totale 5.658
Nome #
Fit and motivated: outcome predictors in patients starting a program for lifestyle change. 323
Inflammatory molecules affect the interaction between human dendritic cells and vascular smooth muscle cells 276
The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence. 271
The therapy of insulin resistance in other diseases besides type 2 diabetes. 241
False and true pre-treatment predictors of weight loss in obese patients starting a program for lifestyle change. 241
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. 226
Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study 221
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 219
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 215
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 197
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. 194
Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity. 193
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials 191
Dendritic cell phenotype and function are modulated by inflammation and insulin-resistance. 184
A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients 178
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 177
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells 175
Clinical approach to diabetic cardiomyopathy: A review of human studies 175
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 173
Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function 171
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 166
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 163
Role of insulin in the type 2 diabetes therapy: past, present and future. 162
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 161
Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better? 161
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough Infection-Associated Changes in Glucose Control in Subjects With Type 1 Diabetes (PRO-VACS 2 Study) 159
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 157
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study-The "PAROdontopatia e DIAbete" (PARODIA) project 155
Assessment of left ventricular global longitudinal strain in patients with type 2 diabetes: Relationship with microvascular damage and glycemic control 154
Periodontitis predicts HbA1c levels and glucose variability in type 1 diabetic patients: the PARODIA Florence Project study 154
Orthorexia nervosa and type 1 diabetes: results of a cross-sectional study 153
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 151
Meccanismi infiammatori regolano le interazioni tra cellule muscolari coronariche lisce e cellule dendritiche umane 149
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 143
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 143
Online group lifestyle modification programs for obesity during the COVID-19 pandemic: The EDucation ONline (EDON) retrospective study 142
Studio del fenotipo delle cellule dendritiche di pazienti obesi ed insulino resistenti e della loro interazione con cellule muscolari lisce coronariche umane. 141
Motivational enhancement therapy in obese patients: A promising application 137
Long-term interactive group education for type 1 diabetic patients 132
Time to insulin in type-2 diabetes: high hurdles or Santiago way? 131
Motivational readiness for treatment in weight control programs: the treatment motivation and readiness (tre-more) test 131
Characterization of dendritic cells in obese and diabetic patients 128
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. 123
Correction to: Orthorexia nervosa and type 1 diabetes: results of a cross‑sectional study (Acta Diabetologica, (2023), 60, 5, (681-686), 10.1007/s00592-023-02044-9) 122
Obesity therapy: How and why? 114
Glucose variability and periodontal disease in type 1 diabetes: a cross-sectional study—The “PAROdontopatia e DIAbete” (PARODIA) project 110
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials 108
MANAGEMENT OF HYPERGLICEMIA IN TYPE 2 DIABETES: A CONSENSUS ALGORITHM FOR THE INITIATION AND ADJUSTMENT OF THERAPY: A CONSENSUS STATEMENT FROM THE AMERICAN DIABETES ASSOCIATION AND THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES 103
The "slower" the better 93
Assessment of psychological predictors of weight loss: How and what for? 24
Validation of a New Test for Assessing the Quality of Life Perceived in Patients with Type 1 Diabetes 21
Totale 8.332
Categoria #
all - tutte 22.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022289 11 7 23 5 11 19 6 16 17 26 58 90
2022/2023900 75 178 38 79 47 155 112 42 122 4 20 28
2023/2024325 17 34 50 18 14 53 19 64 7 17 26 6
2024/20252.379 85 240 148 380 654 370 45 144 91 75 81 66
2025/20262.580 298 309 227 149 279 103 303 133 167 186 63 363
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 8.332